These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23994589)

  • 1. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
    Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
    Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
    Giannopoulos K; Schmitt M; Kowal M; Wlasiuk P; Bojarska-Junak A; Chen J; Rolinski J; Dmoszynska A
    Oncol Rep; 2008 Sep; 20(3):677-82. PubMed ID: 18695923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia.
    Attia MA; Nosair NA; Gawally A; Elnagar G; Elshafey EM
    Acta Haematol; 2014; 132(1):53-8. PubMed ID: 24557341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
    Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
    Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
    Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
    Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-G5 in the blood of leukemia patients and healthy individuals.
    Poláková K; Železníková T; Russ G
    Leuk Res; 2013 Feb; 37(2):139-45. PubMed ID: 23146557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
    Junevik K; Werlenius O; Hasselblom S; Jacobsson S; Nilsson-Ehle H; Andersson PO
    Ann Hematol; 2007 Feb; 86(2):89-94. PubMed ID: 17043777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B; Wooldridge JE; Blackwell SE; Taylor CM; Griffith TS; Link BK; Weiner GJ
    J Leukoc Biol; 2005 Mar; 77(3):378-87. PubMed ID: 15582984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
    Rebmann V; Nückel H; Dührsen U; Grosse-Wilde H
    Semin Cancer Biol; 2007 Dec; 17(6):430-5. PubMed ID: 17683947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.
    Maki G; Hayes GM; Naji A; Tyler T; Carosella ED; Rouas-Freiss N; Gregory SA
    Leukemia; 2008 May; 22(5):998-1006. PubMed ID: 18288133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
    Hammadi A; Billard C; Faussat AM; Kolb JP
    Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.
    Roberti MP; Juliá EP; Rocca YS; Amat M; Bravo AI; Loza J; Coló F; Loza CM; Fabiano V; Maino M; Podhorzer A; Fainboim L; Barrio MM; Mordoh J; Levy EM
    Eur J Immunol; 2015 May; 45(5):1560-9. PubMed ID: 25726929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia.
    Perez-Chacon G; Rosado S; Rebolleda N; Losada-Fernandez I; Vargas JA; Morado M; Jorda J; Perez-Aciego P
    Int J Lab Hematol; 2009 Jun; 31(3):327-37. PubMed ID: 18241213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
    Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
    Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
    Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
    Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.
    Rozková D; Novotná L; Pytlík R; Hochová I; Kozák T; Bartůnková J; Spísek R
    Int J Cancer; 2010 Mar; 126(5):1132-43. PubMed ID: 19685493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.
    Giannopoulos K; Mertens D; Bühler A; Barth TF; Idler I; Möller P; Kröber A; Greiner J; Chocholska S; Dmoszyñska A; Roliñski J; Döhner H; Stilgenbauer S; Schmitt M
    Leukemia; 2009 Mar; 23(3):519-27. PubMed ID: 19092852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G and HLA-E in patients with juvenile idiopathic arthritis.
    Prigione I; Penco F; Martini A; Gattorno M; Pistoia V; Morandi F
    Rheumatology (Oxford); 2011 May; 50(5):966-72. PubMed ID: 21186170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.